***Cite this article as:*** Roushan N, Allameh SF, Eslami O. Case series of papillectomy by endoscopic retrograde cholangiopancreatography (ERCP). *Med J Islam Repub Iran*. 2018(30 May);32:43. https://doi.org/10.14196/mjiri.32.43

↑ What is "already known" in this topic: {#box1}
========================================

Endoscopic papillectomy (EP) is accepted nowadays as an alternative therapy to surgery in ampullary adenoma and has high success and low recurrence rates.

→ What this article adds: {#box2}
=========================

Here we report the result of initial experience of our center in ampullectomy.

Introduction {#s1}
============

Ampullary neoplasms are common cause of obstructive jaundice. Cross sectional imaging like CT scan has only 20 percent sensitivity for diagnosis of ampullary neoplasms. Endoscopic ultrasonography is useful for diagnosing and staging of ampullary neoplasms but it only has 70 percent accuracy for tissue sampling by FNA. ERCP is a gold standard procedure for diagnosing and tissue sampling of ampullary neoplasms. The endoscopic retrograde cholangiopancreatography (ERCP) is nearly 100 percent accurate when ampulla is grossly tumoral or ulcerated.

Gross appearance of ampulla is normal in 30 percent of ampullary neoplasms and physicians only suspect when it is causing obstructive jaundice or grossly prominent. The usual approach for tissue sampling in these lesions is biopsy after sphincterotomy. Even after sphincterotomy the sensitivity of biopsy is low and do not represent the pathology of entire ampulla and most of the times multiple ERCP and biopsy are required ([@R1]).

Ampullectomy by resecting entire ampulla provides whole lesion for pathologic evaluation and also is appropriate for real pathologic staging for further management decision.

As ampullectomy is a heroic endoscopic procedure that gastroenterologists hesitate to perform.

Endoscopic papillectomy (EP) is accepted nowadays as an alternative therapy to surgery in ampullary adenoma and has high success and low recurrence rates.

Endoscopic ampullectomy means the resection of the mucosa and submucosa of the duodenal wall, in attachment area of the ampulla of Vater, including the tissue around the bile duct and the pancreatic duct orifices ([@R2], [@R3]).

The accepted criteria for Endoscopic ampullectomy include a size up to 5 cm, no evidence of malignancy on endoscopic findings, and no evidence of intraductal growth. These indications are in ongoing progress.

Although the endoscopic ampullectomy is a high-risk procedure, it has successfully replaced surgical intervention for benign or malignant papillary tumors. Moreover, the procedur is associated with lower morbidity and mortality in comparison with surgery and seems to be a preferable treatment option for small ampullary tumors without intraductal extension. When Endoscopic ampullectomy performed by an experienced physician, it can lead to successful eradication of tumor in up to 85% of patients with ampullary adenomas. Thus, it is an effective and safe modality and should be established as the first line therapy for ampullary adenomas ([@R4]-[@R6]).

Case series {#s2}
===========

Here we report the result of initial experience of our center in an ampullectomy procedure. In our center we have as first report of 13 patients and the main data are summarized in [Table 1](#T1){ref-type="table"}. Also you can see the ampulla after resection from one patient in [Fig. 1](#F1){ref-type="fig"}.

###### summarized data of patients.

  ----- -------- ------------------------------------- --------------------- ------------------------------------------------------------------------------- -------------------------------
  Age   Sex      Presentation                          Endoscopic findings   Pathology                                                                       Follow up
  63    Female   Icterus and itching                   Prominent ampulla     Tubular adenoma with focal high-grade dysplasia                                 No tumor in control ERCP
  69    Male     Icterus and itching and weight loss   Prominent ampulla     R/O Adenocarcinoma                                                              In follow up
  42    Female   Icterus and itching                   Ampullary polyp       Tubulovillous polyp with low grade dysplasia                                    No tumor in control ERCP
  50    Male     Icterus                               Prominent ampulla     Adenocarcinoma arising in tubular adenoma with invasion to muscularis propria   surgery
  58    Female   Abdominal pain                        Prominent ampulla     Chronic duodenitis                                                              Pancreatitis as a side effect
  48    Male     Icterus                               Tumor of ampulla      Well differentiated neuroendocrine tumor with invasion to duodenal wall         surgery
  81    Female   Abdominal pain                        Prominent ampulla     Hyperplastic polyp                                                              Ok
  64    Female   Fever and icterus                     Tumor of ampulla      Tubulovillous adenoma with focal high-grade dysplasia/T3N1 on EUS               In follow up
  65    Female   Icterus and itching                   Tumor of ampulla      Poorly differentiated adenocarcinoma                                            In follow up
  55    Female   Icterus and itching and weight loss   Tumor of ampulla      R/O Adenocarcinoma                                                              In follow up
  79    Male     Fever and weight loss and Icterus     Prominent ampulla     Invasive adenocarcinoma                                                         In follow up
  70    Female   Icterus                               Prominent ampulla     Well differentiated adenocarcinoma                                              In follow up
  74    Female   Icterus                               Prominent ampulla     Adenocarcinoma well to moderate differentiated                                  In follow up
  ----- -------- ------------------------------------- --------------------- ------------------------------------------------------------------------------- -------------------------------
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Our experience in ampullectomy showed that it is a safe and practical approach for diagnosis and also treatment of ampullary neoplasms.

Discussion {#s3}
==========

In the case series of Shujiro T and his colleagues 80.9 percent of patients treated with single session of ampullectomy with various complications such as pancreatitis, cholangitis, retroperitoneal perforation and bleeding ([@R7]).

Follow-up with surveillance should be performed whithin first 4 to 8weeks after ampullectomy and should be continued for at least three years when the pathology report indicating a high-grade dysplasia. This is because of the possible recurrence of tumor during these years ([@R8]).

In other case series Between January 2008 and November 2011, 12 patients with ampullary tumors underwent endoscopic ampullectomy. The technique was endoscopic double-snare for all 12 patients. The ampullectomy of these patients was safe and complete ([@R9]-[@R11]).

It is standard practice in GI tract to proceed to resect entire lesions like polypoid lesions by simple snare polypectomy or by advance procedures like Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD). We suggest that these approaches also can be useful in ampullary neoplasms because it leads to good diagnostic and curative results with low side effects. The ERCP centers should have good experience with this procedure.
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